Skip to main content

Advertisement

Log in

Treatment adherence in multiple sclerosis: association with emotional status, personality, and cognition

  • Published:
Journal of Behavioral Medicine Aims and scope Submit manuscript

Abstract

The purpose of the present study was to prospectively examine the association between treatment adherence and common neuropsychiatric symptoms in multiple sclerosis (MS). Patients underwent a thorough psychiatric and neuropsychological evaluation at the outset of the study. Patient adherence to disease modifying therapies was then tracked for 8 weeks using self-report, a medication diary, and an electronic monitoring device that recorded needle disposals. Results indicated that MS patients with current mood or anxiety disorders were almost five times as likely as MS patients with no psychiatric diagnosis to exhibit problems adhering to their disease modifying therapies. Poor adherence was also associated with memory difficulties, anxiety, depression, neuroticism, and low conscientiousness. Findings highlight the importance of conducting a thorough psychiatric and neuropsychological evaluation when clinicians suspect poor adherence to disease modifying therapies. Pharmacological or psychotherapeutic treatment of mood/anxiety disorders, use of scheduled reminders, and/or increased organization and structure may lead to improved treatment adherence in MS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Albert, S. M., Flater, S. R., Clouse, R., Todak, G., Stern, Y., & Marder, K. (2003). Medication management skill in HIV: I. Evidence for adaptation of medication management strategies in people with cognitive impairment. II. Evidence for a pervasive lay model of medication efficacy. AIDS and Behavior, 7(3), 329–338.

    Article  PubMed  Google Scholar 

  • Altice, F., & Friedland, G. (1998). The era of adherence to HIV therapy. Annals of Internal Medicine, 129, 503–505.

    CAS  PubMed  Google Scholar 

  • Arnett, P. A. (2003). Neuropsychological presentation and treatment of demyelinating disorders. In U. K. P. Halligan & J. Marshall (Eds.), Handbook of Clinical Neuropsychology (pp. 528–543). Oxford: Oxford University Press.

    Google Scholar 

  • Beck, A. T., Steer, R. A., & Brown, G. K. (2000). BDI-FastScreen for Medical Patients Manual. San Antonio: The Psychological Corporation.

    Google Scholar 

  • Benedict, R. H., Fishman, I., McClellan, M. M., Bakshi, R., & Weinstock-Guttman, B. (2003). Validity of the beck depression inventory-fast screen in multiple sclerosis. Multiple Sclerosis, 9(4), 393–396.

    Article  CAS  PubMed  Google Scholar 

  • Benedict, R. H. B., Priore, R. L., Miller, C., Munschauer, F., & Jacobs, L. (2001). Personality disorder in multiple sclerosis correlates with cognitive impairment. Journal of Neuropsychiatry and Clinical Neurosciences, 13, 70–76.

    CAS  PubMed  Google Scholar 

  • Benedict, R. H. B., Wahlig, E., Bakshi, R., Fishman, I., Munschauer, F., Zivadinov, R., et al. (2005). Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. Journal of Neurological Sciences, 231(1–2), 29–34.

    Article  Google Scholar 

  • Berger, B. A., Hudmon, K. S., & Liang, H. (2004). Predicting treatment discontinuation among patients with multiple sclerosis: application of the transtheoretical model of change. Journal of the American Pharmacists Association, 44(4), 445–454.

    Article  PubMed  Google Scholar 

  • Bosworth, H. (2006). Medication Treatment Adherence. In H. Bosworth, E. Oddone, & M. Weinberger (Eds.), Patient Treatment Adherence: Concepts Interventions, and Measurement. London: Lawrence Erlbaum Associates.

    Google Scholar 

  • Brauner, D., Muir, C., & Sachs, G. (2000). Treating nondementia illnesses in patients with dementia. Journal of the American Medical Association, 283(24), 3230–3235.

    Article  CAS  PubMed  Google Scholar 

  • Bruce, J. M., & Arnett, P. (2009). Clinical correlates of generalized worry in multiple sclerosis. Journal of Clinical and Experimental Neuropsychology, 31(6), 698–705.

    Article  PubMed  Google Scholar 

  • Bruce, J. M., Hancock, L., Lynch, S. (2010). Objective adherence monitoring in MS: Initial validation and association with self-report. Multiple Sclerosis, 16(1), 112–120.

    Article  PubMed  Google Scholar 

  • Costa, P. T., & McCrae, R. R. (1992). Professional manual for the NEO PI-R and NEO-FFI.: Psychological Assessment Resources.

  • Cramer, J. (2004). A systematic review of adherence with medications for diabetes. Diabetes Care, 27(5), 1218–1224.

    Article  PubMed  Google Scholar 

  • Edwards, G. J. B., Leffler, D. A., Dennis, M. D., Franko, D. L., Blom-Hoffman, J., & Kelly, C. P. (2009). Psychological correlates of gluten free diet adherence in adults with celiac disease. Journal of Clinical Gastroenterology, 43(4), 301–306.

    Article  Google Scholar 

  • Fisk, J. D., Pontefract, A., Ritvo, P. G., Archibald, C. J., & Murray, T. J. (1994). The impact of fatigue on patients with multiple sclerosis. Canadian Journal of Neurological Sciences, 21, 9–14.

    CAS  PubMed  Google Scholar 

  • Fraser, C., Morgante, L., Hadjimichael, O., & Vollmer, T. (2004). A prospective study of adherence to glatiramer acetate in individuals with multiple sclerosis. Journal of Neuroscience Nursing, 36(3), 120–129.

    Article  PubMed  Google Scholar 

  • Goodin, D. S. (2008). Disease-modifying therapy in multiple sclerosis: update and clinical implications. Neurology, 71(24 Suppl 3), S8–S13.

    Article  CAS  PubMed  Google Scholar 

  • Grant, D. A., & Berg, E. A. (1948). A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigl-type card-sorting problem. Journal of Experimental Psychology, 38(4), 404–411.

    Article  CAS  PubMed  Google Scholar 

  • Haas, J., & Firzlaff, M. (2005). Twenty-four-month comparison of immunomodulatory treatments—a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (Copaxone). European Journal of Neurology, 12(6), 425–431.

    Article  CAS  PubMed  Google Scholar 

  • Higginson, C. I., Arnett, P. A., & Voss, W. D. (2000). The ecological validity of clinical tests of memory and attention in multiple sclerosis. Archives of Clinical Neuropsychology, 15, 185–204.

    CAS  PubMed  Google Scholar 

  • Insel, K., Morrow, D., Brewer, B., & Figueredo, A. (2006). Executive function, working memory, and medication adherence among older adults. Journal of Gerontology Series B: Psychological Sciences and Social Sciences, 61(2), P102–P107.

    Google Scholar 

  • Inui, T. S., Carter, W. B., & Pecoraro, R. E. (1981). Screening for noncompliance among patients with hypertension: is self-report the best available measure? Medical Care, 19(10), 1061–1064.

    Article  CAS  PubMed  Google Scholar 

  • Korostil, M., & Feinstein, A. (2007). Anxiety disorders and their clinical correlates in multiple sclerosis patients. Multiple Sclerosis, 13(1), 67–72.

    Article  CAS  PubMed  Google Scholar 

  • Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology, 33, 1444–1452.

    CAS  PubMed  Google Scholar 

  • Lezak, M. (1995). Neuropsychological assessment, third edition (3rd ed.). New York: Oxford University Press.

    Google Scholar 

  • Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanandaji, S., et al. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134(10), 968–977.

    CAS  PubMed  Google Scholar 

  • Lublin, F. D., & Reingold, S. C. (1996). Defining the clinical course of multiple sclerosis: Results of an international survey. Neurology, 46, 907–911.

    CAS  PubMed  Google Scholar 

  • Milanese, C., La Mantia, L., Palumbo, R., Martinelli, V., Murialdo, A., Zaffaroni, M., et al. (2003). A post-marketing study on interferon beta 1b and 1a treatment in relapsing-remitting multiple sclerosis: different response in drop-outs and treated patients. Journal of Neurology, Neurosurgery and Psychiatry, 74(12), 1689–1692.

    Article  CAS  Google Scholar 

  • Mohr, D. C., Boudewyn, A. C., Likosky, W., Levine, E., & Goodkin, D. E. (2001). Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject. Annals of Behavioral Medicine, 23(2), 125–132.

    Article  CAS  PubMed  Google Scholar 

  • Mohr, D., & Cox, D. (2001). Multiple sclerosis: empirical literature for the clinical health psychologist. Journal of Clinical Psychology, 57(4), 479–499.

    Article  CAS  PubMed  Google Scholar 

  • Newby, L., LaPointe, N., Chen, A., Kramer, J., Hammill, B., DeLong, E., et al. (2006). Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation, 113, 203–212.

    Article  CAS  PubMed  Google Scholar 

  • O’Rourke, K. E., & Hutchinson, M. (2005). Stopping beta-interferon therapy in multiple sclerosis: an analysis of stopping patterns. Multiple Sclerosis, 11(1), 46–50.

    Article  PubMed  Google Scholar 

  • Pampallona, S., Bollini, P., Tibaldi, G., Kupelnick, B., & Munizza, C. (2002). Patient adherence in the treatment of depression. British Journal of Psychiatry, 180, 104–109.

    Article  CAS  PubMed  Google Scholar 

  • Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H. P., Kappos, L., et al. (2005). Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Annals of Neurology, 58(6), 840–846.

    Article  PubMed  Google Scholar 

  • Portaccio, E., Zipoli, V., Siracusa, G., Sorbi, S., & Amato, M. P. (2008). Long-term adherence to interferon beta therapy in relapsing-remitting multiple sclerosis. European Neurology, 59(3–4), 131–135.

    Article  CAS  PubMed  Google Scholar 

  • Rao, S. M., Leo, G. J., Bernardin, L., & Unverzagt, F. (1991a). Cognitive dysfunction in multiple sclerosis. 1. Frequency, patterns, and prediction. Neurology, 41, 685–691.

    CAS  PubMed  Google Scholar 

  • Rao, S. M., Leo, G. J., Ellington, L., Nauertz, T., Bernardin, L., & Unverzagt, F. (1991b). Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology, 41, 692–696.

    CAS  PubMed  Google Scholar 

  • Rio, J., Porcel, J., Tellez, N., Sanchez-Betancourt, A., Tintore, M., Arevalo, M. J., et al. (2005). Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis. Multiple Sclerosis, 11(3), 306–309.

    Article  CAS  PubMed  Google Scholar 

  • Ruggieri, R. M., Settipani, N., Viviano, L., Attanasio, M., Giglia, L., Almasio, P., et al. (2003). Long-term interferon-beta treatment for multiple sclerosis. Neurological Science, 24(5), 361–364.

    Article  CAS  Google Scholar 

  • Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., et al. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(20), 22–33.

    PubMed  Google Scholar 

  • Smith, A. (1982). Symbol Digit Modalities Test (SDMT) Manual (Revised). Los Angeles: Western Psychological Services.

    Google Scholar 

  • Spielberger, C. D. (1983). Manual for the State-Trait Anxiety Inventory. Palo Alto: Consulting Psychologists Press.

    Google Scholar 

  • Stein, M., Cantrell, C., Sokol, M., Eaddy, M., & Shah, M. (2006). Antidepressant adherence and medical resource use among managed care patients with anxiety disorders. Psychiatric Services, 57(5), 673–680.

    Article  PubMed  Google Scholar 

  • Stilley, C. S., Sereika, S., Muldoon, M. F., Ryan, C. M., & Dunbar-Jacob, J. (2004). Psychological and cognitive function: predictors of adherence with cholesterol lowering treatment. Annals of Behavioral Medicine, 27(2), 117–124.

    Article  PubMed  Google Scholar 

  • Stroop, J. R. (1935). Studies of interference in serial verbal reactions. Journal of Experimental Psychology, 18, 643–662.

    Article  Google Scholar 

  • Tremlett, H. L., & Oger, J. (2003). Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS. Neurology, 61(4), 551–554.

    PubMed  Google Scholar 

  • Turner, A. P., Kivlahan, D. R., Sloan, A. P., & Haselkorn, J. K. (2007). Predicting ongoing adherence to disease modifying therapies in multiple sclerosis: utility of the health beliefs model. Multiple Sclerosis, 13(9), 1146–1152.

    Article  CAS  PubMed  Google Scholar 

  • Van Houtven, C., Weinberger, M., & Carey, T. (2006). Implications of nonadherence for economic evaluation and health policy. In H. Bosworth, E. Oddone, & M. Weinberger (Eds.), Patient Treatment Adherence: Concepts, Interventions, and Measurement. London: Lawrence Erlbaum Associates.

    Google Scholar 

  • Wechsler, D. (1997). Wechsler Adult Intelligence Scale (3rd ed.). San Antonio: The Psychological Corporation.

    Google Scholar 

  • Wetherell, J., & Unutzer, J. (2003). Adherence to treatment for geriatric depression and anxiety. CNS Spectrums, 8(12 supplement 3), 48–59.

    PubMed  Google Scholar 

  • Woods, S. P., Moran, L. M., Dawson, M. S., Carey, C. L., & Grant, I. (2008). Psychometric characteristics of the memory for intentions screening test. The Clinical Neuropsychologist, 22(5), 864–878.

    Article  PubMed  Google Scholar 

  • World Health Organization. (2003). Adherence to Long-term Therapies: Evidence for Action. Geneva: WHO.

    Google Scholar 

  • Zeller, A., Ramseier, E., Teagtmeyer, A., & Battegay, E. (2008). Patients’ self-reported adherence to cardiovascular medication using electronic monitors as comparators. Hypertension Research, 31(11), 2037–2043.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to express their gratitude to research assistants Shelly Peterson, Dr. John Jacobson, Josie Tyrer, Emily Guse, Meghan Murphy, Justin Lasater, Lisa Bratcher, and JaNae Fritz. The authors would also like to thank Dr. Amanda Bruce for her thoughtful edits.

Funding

This study was funded in part by pilot grant PP1506 from the National Multiple Sclerosis Society.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jared M. Bruce.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bruce, J.M., Hancock, L.M., Arnett, P. et al. Treatment adherence in multiple sclerosis: association with emotional status, personality, and cognition. J Behav Med 33, 219–227 (2010). https://doi.org/10.1007/s10865-010-9247-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10865-010-9247-y

Keywords

Navigation